However, a recent report pointed out that in NAFLD, the intrahepatic tumor-suppressive CD4+ T cells were selectively damaged, leading to the disorder of lipid metabolism [16]. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.